{"id":"W1969836944","doi":"10.3109/15412555.2012.661492","title":"Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)","year":2012,"lang":"en","type":"article","venue":"COPD Journal of Chronic Obstructive Pulmonary Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Placebo; Anticholinergic; Adverse effect; Internal medicine; Randomized controlled trial; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00180768,0.001140552,0.002959349,0.0004093098,0.0004894758,0.0008331474,0.0009147239,0.001854331,0.002799663],"category_scores_gemma":[0.001006168,0.0006147894,0.00137985,0.0002975681,0.0006501764,0.0006007368,0.0004240092,0.002495998,0.0008048812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004065246,"about_ca_system_score_gemma":0.0008982362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006158357,"about_ca_topic_score_gemma":0.001116678,"domain_scores_codex":[0.9994469,0.0002747707,0.00004802345,0.0001039529,0.00005320895,0.0000730098],"domain_scores_gemma":[0.9989076,0.0002086083,0.0003346551,0.00009955047,0.00007896697,0.0003707086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8936429,0.03323818,0.002629546,0.000583188,0.0005886464,0.0000420078,0.00009433331,0.0003838044,0.02117674,0.00002720694,0.00057016,0.04702326],"study_design_scores_gemma":[0.6363114,0.3515207,0.009326716,0.00003556176,0.0003581254,0.00005297145,0.00002032497,0.0003093187,0.00154459,0.00002368558,0.0004758033,0.00002092249],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949291,0.002256265,0.0003573874,0.000183841,0.00009436674,0.001202805,0.0003499662,0.00008924424,0.0005370393],"genre_scores_gemma":[0.990054,0.001485219,0.001963728,0.0007547666,0.0002500312,0.002932777,0.0009652819,0.00002442231,0.001569858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002959349,"threshold_uncertainty_score":0.009559989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01761478852979394,"score_gpt":0.2743072810772876,"score_spread":0.2566924925474937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}